We use cookies to give you the best experience on our website. By continuing to use the site, you agree to our privacy policy.
Learn More
OK
June 2 - 5, 2026
About
Exhibition
2026 Exhibitors
2026 Pavillions
2026 Floor Plan
Matchmaking
Events
Stage Agenda
Stage Programs
Speakers
Pitch Contest
Award Winners
InnoVEX Night
Exhibitor Events
Partnership Events
Media
News Release
Exhibitor News
Interview
Videos
Photos
Weekly Newsletter
Partners
Login
中
2023 Finals
Share
Share
×
 
KAICO LTD.
Japan
Healthcare & Biotech
Funding Stage: N/A
Founding Year: 2018
Looking for
Investors
Partners
Manufacturers
Markets
Promotion
Mentors
Media
Other
Product/Solution
Oral Vaccine, Feed Additive, Antibody Test Kit
Company Description
KAICO creates hard-to-express proteins by using specially bred silkworms. KAICO develop cytokines and enzymes for medicine, diagnostic agent, and reagent with silkworms
Back